Please assess the completion status of the following clinical trial:

Trial Title: Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18 to 90 years.~* History of coronary artery disease.~* Presence of, or planned for, an ICD prior to discharge.~* Presentation for management of ICD shock/ATP therapy or monomorphic ventricular tachycardia.~Exclusion Criteria:~* Ventricular arrhythmia not thought to be due to CAD.~* Unstable angina~* CVA within 30 days.~* Protruding left ventricular thrombus or critical aortic stenosis on pre-ablation echocardiography~* Pregnancy~* Any condition resulting in an absolute contraindication to anticoagulation~* Inability to follow-up at ICD clinic.~* Inability to give informed consent.~* Non-inducible for sustained monomorphic ventricular tachycardia.~* Prior substrate guided ablation.~* Definite need for epicardial ablation, as determined by the primary operator.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- catheter-based ablation (Type: OTHER): catheter ablation - a medical procedure used to treat some types of arrhythmia

Based on this trial design, predict the completion outcome and termination type (if applicable).